FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025249056> ?p ?o ?g. }

• W2025249056 endingPage "134" @default.
• W2025249056 startingPage "124" @default.
• W2025249056 abstract "This study is a post hoc analysis of additions of antidepressants, anxiolytics, and sedative/hypnotics in treatment of patients randomized to antipsychotic treatment in the CATIE study, which recruited a chronic, real world schizophrenia sample and followed patients for up to eighteen months. We examined baseline predictors of initiation, time until initiation, and duration of treatment with antidepressants, anxiolytics, and sedative/hypnotics in CATIE study participants.Psychotropic medication use by 1,449 CATIE study participants was documented at each study visit. Baseline demographic and clinical predictors of initiation, of time to initiation, and of duration of treatment of Concomitant Psychotropic Medications (CPMs) in each category (antidepressant, anxiolytic, and sedative/hypnotics) were identified through multiple regression analyses.Initiation of new CPMs post baseline by CATIE clinicians was moderately frequent, with 14.6% of patients receiving antidepressants, 13.7% receiving anxiolytics, and 11.2% receiving sedative/hypnotics. Predictors of antidepressant initiation (14.6% of group) were being female or white, and having a prior diagnosis of depression or symptoms of depression at baseline. Patients with higher positive symptom scores and younger patients were started on antidepressants sooner. Duration of antidepressant treatment was longer in patients with less education and in those with a history of alcohol abuse/dependence. Predictors of anxiolytic initiation (13.7% of group) were not being of African-American race, being separated/divorced, younger age, higher body mass index, and akathisia. Time to anxiolytic initiation was shorter in patients who were separated or divorced and in patients with better neurocognitive functioning. Duration of anxiolytic treatment was shorter for African Americans and longer in patients with better instrumental role functioning. Predictors of sedative/hypnotic use (11.2% of group) were depressive symptoms and prior diagnosis of an anxiety disorder. Time to initiation of sedative/hypnotics was longer for those with depressive symptoms and shorter for those with a history of alcohol abuse/dependence.Sedative/hypnotics, anxiolytics, and antidepressants were commonly used CPMs in schizophrenia during the CATIE trial, where patients were being seen frequently and antipsychotic treatment was optimized. Randomized, controlled clinical trials examining adjunctive use of antidepressants, anxiolytics and sedative/hypnotics to target symptoms of anxiety, depression, and insomnia in patients with schizophrenia are needed to adequately address the efficacy of these interventions." @default.
• W2025249056 created "2016-06-24" @default.
• W2025249056 creator A5000014963 @default.
• W2025249056 creator A5021201603 @default.
• W2025249056 creator A5027752754 @default.
• W2025249056 creator A5042757811 @default.
• W2025249056 creator A5050682054 @default.
• W2025249056 creator A5051287955 @default.
• W2025249056 creator A5055188019 @default.
• W2025249056 creator A5055937650 @default.
• W2025249056 date "2011-10-01" @default.
• W2025249056 modified "2023-10-16" @default.
• W2025249056 title "Concomitant Psychotropic Medication Use During Treatment of Schizophrenia Patients: Longitudinal Results from the CATIE Study" @default.
• W2025249056 cites W1571310866 @default.
• W2025249056 cites W1965375866 @default.
• W2025249056 cites W1965458709 @default.
• W2025249056 cites W1970183418 @default.
• W2025249056 cites W1975586101 @default.
• W2025249056 cites W1981186498 @default.
• W2025249056 cites W1986608284 @default.
• W2025249056 cites W1999689270 @default.
• W2025249056 cites W2002703519 @default.
• W2025249056 cites W2005971050 @default.
• W2025249056 cites W2009187459 @default.
• W2025249056 cites W2011613229 @default.
• W2025249056 cites W2014151794 @default.
• W2025249056 cites W2014555657 @default.
• W2025249056 cites W2023289842 @default.
• W2025249056 cites W2033122892 @default.
• W2025249056 cites W2046175931 @default.
• W2025249056 cites W2050309190 @default.
• W2025249056 cites W2051117480 @default.
• W2025249056 cites W2054151566 @default.
• W2025249056 cites W2056061093 @default.
• W2025249056 cites W2067105869 @default.
• W2025249056 cites W2070893229 @default.
• W2025249056 cites W2079773995 @default.
• W2025249056 cites W2093420318 @default.
• W2025249056 cites W2095559540 @default.
• W2025249056 cites W2096782637 @default.
• W2025249056 cites W2104706609 @default.
• W2025249056 cites W2111324481 @default.
• W2025249056 cites W2115411118 @default.
• W2025249056 cites W2117058794 @default.
• W2025249056 cites W2127281950 @default.
• W2025249056 cites W2140275529 @default.
• W2025249056 cites W2140606211 @default.
• W2025249056 cites W2144393454 @default.
• W2025249056 cites W2146039150 @default.
• W2025249056 cites W2147342661 @default.
• W2025249056 cites W2149639459 @default.
• W2025249056 cites W2152384697 @default.
• W2025249056 cites W2153393568 @default.
• W2025249056 cites W2157130535 @default.
• W2025249056 cites W2158866704 @default.
• W2025249056 cites W2159155203 @default.
• W2025249056 cites W2166842956 @default.
• W2025249056 cites W2183656574 @default.
• W2025249056 cites W3022619031 @default.
• W2025249056 cites W62870477 @default.
• W2025249056 cites W64322893 @default.
• W2025249056 doi "https://doi.org/10.3371/csrp.5.3.2" @default.
• W2025249056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21983496" @default.
• W2025249056 hasPublicationYear "2011" @default.
• W2025249056 type Work @default.
• W2025249056 sameAs 2025249056 @default.
• W2025249056 citedByCount "20" @default.
• W2025249056 countsByYear W20252490562012 @default.
• W2025249056 countsByYear W20252490562013 @default.
• W2025249056 countsByYear W20252490562015 @default.
• W2025249056 countsByYear W20252490562016 @default.
• W2025249056 countsByYear W20252490562017 @default.
• W2025249056 countsByYear W20252490562020 @default.
• W2025249056 countsByYear W20252490562022 @default.
• W2025249056 countsByYear W20252490562023 @default.
• W2025249056 crossrefType "journal-article" @default.
• W2025249056 hasAuthorship W2025249056A5000014963 @default.
• W2025249056 hasAuthorship W2025249056A5021201603 @default.
• W2025249056 hasAuthorship W2025249056A5027752754 @default.
• W2025249056 hasAuthorship W2025249056A5042757811 @default.
• W2025249056 hasAuthorship W2025249056A5050682054 @default.
• W2025249056 hasAuthorship W2025249056A5051287955 @default.
• W2025249056 hasAuthorship W2025249056A5055188019 @default.
• W2025249056 hasAuthorship W2025249056A5055937650 @default.
• W2025249056 hasConcept C118552586 @default.
• W2025249056 hasConcept C126322002 @default.
• W2025249056 hasConcept C139719470 @default.
• W2025249056 hasConcept C162324750 @default.
• W2025249056 hasConcept C2776412080 @default.
• W2025249056 hasConcept C2776867660 @default.
• W2025249056 hasConcept C2777393122 @default.
• W2025249056 hasConcept C2777602617 @default.
• W2025249056 hasConcept C2777765862 @default.
• W2025249056 hasConcept C2779177272 @default.
• W2025249056 hasConcept C2779384505 @default.
• W2025249056 hasConcept C2780494398 @default.
• W2025249056 hasConcept C558461103 @default.
• W2025249056 hasConcept C71924100 @default.

• next